Midodrine Hydrochloride in Early Sepsis

Completed · Phase 1 · Has a placebo group

Conditions studied: Sepsis, Blood Pressure

In brief

The investigators would like to determine if early administration of oral Midodrine in participants diagnosed with sepsis will impact blood pressures and decrease the need for and/or doses of intravenous pressor agents.

Key facts

Study ID
NCT03129542
Run by
Mayo Clinic
People needed
33
Starts
2017-08-30
Expected to finish
2020-05-15
Last updated by the study team
2021-02-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.